![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » ABMC RECEIVES FDA CLEARANCE ON ITS BUPRENORPHINE TEST
ABMC RECEIVES FDA CLEARANCE ON ITS BUPRENORPHINE TEST
August 10, 2006
American Bio Medica Corporation announced that the US Food and Drug Administration (FDA) has granted the Company 510(k) clearance on its Rapid One lateral flow immunoassay test for the detection of Buprenorphine. Buprenorphine is semi-synthetic narcotic used in the treatment of narcotics addiction.
Genetic
Engineering News
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct